Cost-minimization analysis of intravenous adenosine and dipyridamole in thallous chloride TI 201 SPECT myocardial perfusion imaging

Annals of Pharmacotherapy

Volumn 31, Issue 9, 1997, Pages 974-979

  Hilleman, Daniel E ^a   Lucas Jr , B Daniel ^b   Mohiuddin, Syed M ^c   Holmberg, M Jeffrey ^c  

^a CREIGHTON UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; Cost minimization; Dipyridamole; Myocardial perfusion imaging

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; THALLIUM 201;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; COST CONTROL; DIAGNOSTIC IMAGING; DRUG INDUCED DISEASE; DYSPNEA; FEMALE; HEADACHE; HEART INFARCTION; HEART MUSCLE PERFUSION; HEMODYNAMIC PARAMETERS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX PAIN;

EID: 0030799444     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100903     Document Type: Article

References (17)

1. Rossen JD, Simonetti I, Marcus ML, Winniford MD. Coronary dilation with standard dose dipyridamole and dipyridamole combined with handgrip. Circulation 1989;79:566-72.
2. Lam JYT, Chaitman BR, Glaenzer M. Safety and diagnostic accuracy of dipyridamole-thallium imaging in the elderly. J Am Coll Cardiol 1988; 11:585-9.
3. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson D. Effects of adenosine on human coronary arterial circulation. Circulation 1990; 82:1595-606.
4. Klabunde RD. Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol 1983;93:21-6.
5. Package insert. Adenoscan (adenosine). Fujisawa USA, Inc., 1996.
6. Package insert. I.V. Persantine (dipyridamole). USP DuPont Pharma, 1995.
7. Gupta NC, Esterbrooks DJ, Hilleman DE, Mohiuddin SM. Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. J Am Coll Cardiol 1992;19:248-57.
8. Belardinelli L, Linden J, Berne R. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989;32:73-97.
9. Moser GH, Schroder J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol 1989;256:C799-806.
10. Hanley FL, Grattan MT, Stevens MB, Hoffman JIE. Role of adenosine in coronary autoregulation. Am J Physiol 1986;250:H558-66.
11. Kurtz A. Adenosine stimulates guaylate cyclase activity in vascular smooth muscles. J Biol Chem 1987;262:6296-300.
12. Iskandrian AS, Heo J, Askenase A, Segal BL, Auerbach N. Dipyridamole cardiac imaging. Am Heart J 1988;115:432-43.
13. Gould KL. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacological coronary vasodilation: physiological basis and experimental vasodilation. Am J Cardiol 1978;41:269-78.
14. Picano E. Dipyridamole-echocardiography test: historical background and physiologic basis. Eur Heart J 1989;10:365-476.
15. Ranhosky A, Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation 1990;81: 384-9.
16. Cerqueria M, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging in 9,256 patients. Results from the adenoscan multicenter trial registry. J Am Coll Cardiol 1994; 23:384-9.
17. Taillefer R, Amyot R, Turpin S, Lambert R, Pilot C, Jarry M, et al. Comparison between dipyridamole and adenosine in detection of coronary artery disease with TI-201 imaging. J Nucl Cardiol 1996;3:36-77.